APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non Narcotic Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non Narcotic Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174017640326 December 2025186 pages

Choose your research edition.

Industry ResearchNon Narcotic Analgesics Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Non Narcotic Analgesics Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Non Narcotic Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non Narcotic Analgesics Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Non Narcotic Analgesics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Non Narcotic Analgesics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non Narcotic Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non Narcotic Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non Narcotic Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non Narcotic Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non Narcotic Analgesics include Endo Pharmaceuticals, Reckitt Benckiser, GlaxoSmithKline PLC, Pfizer, Novartis AG and Sanofi S.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non Narcotic Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non Narcotic Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non Narcotic Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non Narcotic Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Non Narcotic Analgesics Segment by Company

Endo Pharmaceuticals

Reckitt Benckiser

GlaxoSmithKline PLC

Pfizer

Novartis AG

Sanofi S.A.

Non Narcotic Analgesics Segment by Type

Non Steroid Antiinflammatory Drug

Steroid Antiinflammatory Drug

Non Narcotic Analgesics Segment by Application

Hospital

Medical Center

Others

Non Narcotic Analgesics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non Narcotic Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non Narcotic Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non Narcotic Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non Narcotic Analgesics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non Narcotic Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non Narcotic Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non Narcotic Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non Narcotic Analgesics Industry Trends Table 2. Non Narcotic Analgesics Industry Drivers Table 3. Non Narcotic Analgesics Industry Opportunities and Challenges Table 4. Non Narcotic Analgesics Industry Restraints Table 5. Global Non Narcotic Analgesics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non Narcotic Analgesics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non Narcotic Analgesics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Non Narcotic Analgesics Sales Market Share by Manufacturers Table 9. Global Non Narcotic Analgesics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Non Narcotic Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non Narcotic Analgesics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non Narcotic Analgesics Manufacturers, Product Type & Application Table 13. Global Non Narcotic Analgesics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non Narcotic Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Non Steroid Antiinflammatory Drug Table 17. Major Manufacturers of Steroid Antiinflammatory Drug Table 18. Global Non Narcotic Analgesics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Non Narcotic Analgesics Sales by Type (2021-2026) & (K Units) Table 20. Global Non Narcotic Analgesics Sales by Type (2027-2032) & (K Units) Table 21. Global Non Narcotic Analgesics Sales Market Share by Type (2021-2026) Table 22. Global Non Narcotic Analgesics Sales Market Share by Type (2027-2032) Table 23. Global Non Narcotic Analgesics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Non Narcotic Analgesics Revenue by Type (2021-2026) & (K Units) Table 25. Global Non Narcotic Analgesics Revenue by Type (2027-2032) & (K Units) Table 26. Global Non Narcotic Analgesics Revenue Market Share by Type (2021-2026) Table 27. Global Non Narcotic Analgesics Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Medical Center Table 30. Major Manufacturers of Others Table 31. Global Non Narcotic Analgesics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Non Narcotic Analgesics Sales by Application (2021-2026) & (K Units) Table 33. Global Non Narcotic Analgesics Sales by Application (2027-2032) & (K Units) Table 34. Global Non Narcotic Analgesics Sales Market Share by Application (2021-2026) Table 35. Global Non Narcotic Analgesics Sales Market Share by Application (2027-2032) Table 36. Global Non Narcotic Analgesics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Non Narcotic Analgesics Revenue by Application (2021-2026) & (K Units) Table 38. Global Non Narcotic Analgesics Revenue by Application (2027-2032) & (K Units) Table 39. Global Non Narcotic Analgesics Revenue Market Share by Application (2021-2026) Table 40. Global Non Narcotic Analgesics Revenue Market Share by Application (2027-2032) Table 41. Global Non Narcotic Analgesics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Non Narcotic Analgesics Sales by Region (2021-2026) & (K Units) Table 43. Global Non Narcotic Analgesics Sales Market Share by Region (2021-2026) Table 44. Global Non Narcotic Analgesics Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Non Narcotic Analgesics Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Non Narcotic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Non Narcotic Analgesics Sales by Country (2021-2026) & (K Units) Table 48. North America Non Narcotic Analgesics Sales by Country (2027-2032) & (K Units) Table 49. Europe Non Narcotic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Non Narcotic Analgesics Sales by Country (2021-2026) & (K Units) Table 51. Europe Non Narcotic Analgesics Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Non Narcotic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Non Narcotic Analgesics Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Non Narcotic Analgesics Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Non Narcotic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Non Narcotic Analgesics Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Non Narcotic Analgesics Sales by Country (2027-2032) & (K Units) Table 58. Global Non Narcotic Analgesics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Non Narcotic Analgesics Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Non Narcotic Analgesics Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Non Narcotic Analgesics Revenue Market Share by Region (2021-2026) Table 62. Global Non Narcotic Analgesics Revenue Market Share by Region (2027-2032) Table 63. Endo Pharmaceuticals Company Information Table 64. Endo Pharmaceuticals Business Overview Table 65. Endo Pharmaceuticals Non Narcotic Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Endo Pharmaceuticals Non Narcotic Analgesics Product Portfolio Table 67. Endo Pharmaceuticals Recent Development Table 68. Reckitt Benckiser Company Information Table 69. Reckitt Benckiser Business Overview Table 70. Reckitt Benckiser Non Narcotic Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Reckitt Benckiser Non Narcotic Analgesics Product Portfolio Table 72. Reckitt Benckiser Recent Development Table 73. GlaxoSmithKline PLC Company Information Table 74. GlaxoSmithKline PLC Business Overview Table 75. GlaxoSmithKline PLC Non Narcotic Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline PLC Non Narcotic Analgesics Product Portfolio Table 77. GlaxoSmithKline PLC Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Non Narcotic Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pfizer Non Narcotic Analgesics Product Portfolio Table 82. Pfizer Recent Development Table 83. Novartis AG Company Information Table 84. Novartis AG Business Overview Table 85. Novartis AG Non Narcotic Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Novartis AG Non Narcotic Analgesics Product Portfolio Table 87. Novartis AG Recent Development Table 88. Sanofi S.A. Company Information Table 89. Sanofi S.A. Business Overview Table 90. Sanofi S.A. Non Narcotic Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sanofi S.A. Non Narcotic Analgesics Product Portfolio Table 92. Sanofi S.A. Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Non Narcotic Analgesics Distributors List Table 96. Non Narcotic Analgesics Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Non Narcotic Analgesics Product Image Figure 2. Global Non Narcotic Analgesics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non Narcotic Analgesics Market Size (2021-2032) & (US$ Million) Figure 4. Global Non Narcotic Analgesics Sales (2021-2032) & (K Units) Figure 5. Global Non Narcotic Analgesics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non Narcotic Analgesics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Non Steroid Antiinflammatory Drug Image Figure 9. Steroid Antiinflammatory Drug Image Figure 10. Global Non Narcotic Analgesics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Non Narcotic Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Non Narcotic Analgesics Sales Market Share by Type (2021-2032) Figure 13. Global Non Narcotic Analgesics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Non Narcotic Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Non Narcotic Analgesics Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Medical Center Image Figure 18. Others Image Figure 19. Global Non Narcotic Analgesics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Non Narcotic Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Non Narcotic Analgesics Sales Market Share by Application (2021-2032) Figure 22. Global Non Narcotic Analgesics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Non Narcotic Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Non Narcotic Analgesics Revenue Market Share by Application (2021-2032) Figure 25. North America Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Non Narcotic Analgesics Sales Market Share by Country (2021-2032) Figure 27. U.S. Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Non Narcotic Analgesics Sales Market Share by Country (2021-2032) Figure 32. Germany Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Non Narcotic Analgesics Sales Market Share by Country (2021-2032) Figure 39. China Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Non Narcotic Analgesics Sales Market Share by Country (2021-2032) Figure 47. Brazil Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Non Narcotic Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Non Narcotic Analgesics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Non Narcotic Analgesics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Non Narcotic Analgesics Revenue (2021-2032) & (US$ Million) Figure 58. North America Non Narcotic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Non Narcotic Analgesics Revenue (2021-2032) & (US$ Million) Figure 60. Europe Non Narcotic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Non Narcotic Analgesics Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Non Narcotic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Non Narcotic Analgesics Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Non Narcotic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Non Narcotic Analgesics Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Non Narcotic Analgesics Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Non Steroid Antiinflammatory Drug
  • Steroid Antiinflammatory Drug
Applications
  • Hospital
  • Medical Center
  • Others
Companies covered
  • Endo Pharmaceuticals
  • Reckitt Benckiser
  • GlaxoSmithKline PLC
  • Pfizer
  • Novartis AG
  • Sanofi S.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non Narcotic Analgesics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non Narcotic Analgesics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non Narcotic Analgesics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non Narcotic Analgesics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non Narcotic Analgesics Market Dynamics
  1. 2.1 Non Narcotic Analgesics Industry Trends
  2. 2.2 Non Narcotic Analgesics Industry Drivers
  3. 2.3 Non Narcotic Analgesics Industry Opportunities and Challenges
  4. 2.4 Non Narcotic Analgesics Industry Restraints
3 Non Narcotic Analgesics Market by Manufacturers
  1. 3.1 Global Non Narcotic Analgesics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non Narcotic Analgesics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non Narcotic Analgesics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non Narcotic Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non Narcotic Analgesics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non Narcotic Analgesics Manufacturers, Product Type & Application
  7. 3.7 Global Non Narcotic Analgesics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non Narcotic Analgesics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non Narcotic Analgesics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non Narcotic Analgesics Tier 1, Tier 2, and Tier 3
4 Non Narcotic Analgesics Market by Type
  1. 4.1 Non Narcotic Analgesics Type Introduction
  2. 4.1.1 Non Steroid Antiinflammatory Drug
  3. 4.1.2 Steroid Antiinflammatory Drug
  4. 4.2 Global Non Narcotic Analgesics Sales by Type
  5. 4.2.1 Global Non Narcotic Analgesics Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non Narcotic Analgesics Sales by Type (2021-2032)
  7. 4.2.3 Global Non Narcotic Analgesics Sales Market Share by Type (2021-2032)
  8. 4.3 Global Non Narcotic Analgesics Revenue by Type
  9. 4.3.1 Global Non Narcotic Analgesics Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Non Narcotic Analgesics Revenue by Type (2021-2032)
  11. 4.3.3 Global Non Narcotic Analgesics Revenue Market Share by Type (2021-2032)
5 Non Narcotic Analgesics Market by Application
  1. 5.1 Non Narcotic Analgesics Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Medical Center
  4. 5.1.3 Others
  5. 5.2 Global Non Narcotic Analgesics Sales by Application
  6. 5.2.1 Global Non Narcotic Analgesics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non Narcotic Analgesics Sales by Application (2021-2032)
  8. 5.2.3 Global Non Narcotic Analgesics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Non Narcotic Analgesics Revenue by Application
  10. 5.3.1 Global Non Narcotic Analgesics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non Narcotic Analgesics Revenue by Application (2021-2032)
  12. 5.3.3 Global Non Narcotic Analgesics Revenue Market Share by Application (2021-2032)
6 Global Non Narcotic Analgesics Sales by Region
  1. 6.1 Global Non Narcotic Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non Narcotic Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Non Narcotic Analgesics Sales by Region (2021-2026)
  4. 6.2.2 Global Non Narcotic Analgesics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non Narcotic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non Narcotic Analgesics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non Narcotic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non Narcotic Analgesics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non Narcotic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non Narcotic Analgesics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non Narcotic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non Narcotic Analgesics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non Narcotic Analgesics Revenue by Region
  1. 7.1 Global Non Narcotic Analgesics Revenue by Region
  2. 7.1.1 Global Non Narcotic Analgesics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non Narcotic Analgesics Revenue by Region (2021-2026)
  4. 7.1.3 Global Non Narcotic Analgesics Revenue by Region (2027-2032)
  5. 7.1.4 Global Non Narcotic Analgesics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non Narcotic Analgesics Revenue (2021-2032)
  8. 7.2.2 North America Non Narcotic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non Narcotic Analgesics Revenue (2021-2032)
  11. 7.3.2 Europe Non Narcotic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non Narcotic Analgesics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non Narcotic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non Narcotic Analgesics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non Narcotic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Endo Pharmaceuticals
  2. 8.1.1 Endo Pharmaceuticals Company Information
  3. 8.1.2 Endo Pharmaceuticals Business Overview
  4. 8.1.3 Endo Pharmaceuticals Non Narcotic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Endo Pharmaceuticals Non Narcotic Analgesics Product Portfolio
  6. 8.1.5 Endo Pharmaceuticals Recent Developments
  7. 8.2 Reckitt Benckiser
  8. 8.2.1 Reckitt Benckiser Company Information
  9. 8.2.2 Reckitt Benckiser Business Overview
  10. 8.2.3 Reckitt Benckiser Non Narcotic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Reckitt Benckiser Non Narcotic Analgesics Product Portfolio
  12. 8.2.5 Reckitt Benckiser Recent Developments
  13. 8.3 GlaxoSmithKline PLC
  14. 8.3.1 GlaxoSmithKline PLC Company Information
  15. 8.3.2 GlaxoSmithKline PLC Business Overview
  16. 8.3.3 GlaxoSmithKline PLC Non Narcotic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline PLC Non Narcotic Analgesics Product Portfolio
  18. 8.3.5 GlaxoSmithKline PLC Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Non Narcotic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Non Narcotic Analgesics Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Novartis AG
  26. 8.5.1 Novartis AG Company Information
  27. 8.5.2 Novartis AG Business Overview
  28. 8.5.3 Novartis AG Non Narcotic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis AG Non Narcotic Analgesics Product Portfolio
  30. 8.5.5 Novartis AG Recent Developments
  31. 8.6 Sanofi S.A.
  32. 8.6.1 Sanofi S.A. Company Information
  33. 8.6.2 Sanofi S.A. Business Overview
  34. 8.6.3 Sanofi S.A. Non Narcotic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi S.A. Non Narcotic Analgesics Product Portfolio
  36. 8.6.5 Sanofi S.A. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non Narcotic Analgesics Value Chain Analysis
  2. 9.1.1 Non Narcotic Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non Narcotic Analgesics Production Mode & Process
  6. 9.2 Non Narcotic Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non Narcotic Analgesics Distributors
  9. 9.2.3 Non Narcotic Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst